A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative analyses is a dataset published in Journal for ImmunoTherapy of Cancer (2024). On theSindex it has a DataRank of 0.618, placing it in the top 32% of the data-sharing corpus. It has been cited 16 times, with 14 citing works in its 1-hop citation network. Its calibrated FAIR score is 54/100.
Ranks in the top 32% for downstream scientific impact
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
Full FAIR picture · advisory
The headline score is computed from the scored criteria — the fact-shaped checks (a repository, an accession, a licence) that two independent models agree on. The advisory criteria below are real FAIR guidance but rest on judgment calls that models read differently, so they inform without moving the number.
“Data are available, via controlled access, from the NCBI dbGaP archive (database accession number phs003785.v1).”
The identifier string 'phs003785.v1' is a dbGaP accession, which is a persistent identifier scheme.
RDA-F1-01D — FAIR Data Maturity Model: 'Data is identified by a persistent identifier' (priorit · RDA-F1-02D — FAIR Data Maturity Model: 'Data is identified by a globally unique identifier' · FsF-F1-02D — F-UJI/FAIRsFAIR: 'Data is assigned a persistent identifier'
“Data are available, via controlled access, from the NCBI dbGaP archive (database accession number phs003785.v1).”
The named repository is NCBI dbGaP, which is listed in re3data/FAIRsharing.
RDA-F4-01M — FAIR Data Maturity Model: metadata is offered so it can be harvested and indexed ( · NIH DMS Policy Element 4 (NOT-OD-21-014) — name the repository where data will be archived · NSTC Desirable Characteristics of Data Repositories (2022) — 'Long-Term Sustainability', 'Reten
“Data are available, via controlled access, from the NCBI dbGaP archive (database accession number phs003785.v1).”
The dataset identifier (phs003785.v1) appears only in the body text, not in the reference list.
FORCE11 Joint Declaration of Data Citation Principles (2014) — data should be cited as a first- · RDA-F3-01M — metadata clearly and explicitly includes the identifier of the data it describes · FsF-F3-01M — F-UJI: 'Metadata includes the identifier of the data it describes'
Advisory · not in the published score
“Data are available, via controlled access, from the NCBI dbGaP archive (database accession number phs003785.v1).”
The statement points at a repository record: it names a repository (dbGaP) and carries an accession (phs003785.v1).
Colavizza, Hrynaszkiewicz, Staden, Whitaker & McGillivray (2020), 'The citation advantage of li · Springer Nature research data policy — Data Availability Statements: standard statement templat · RDA-F3-01M — metadata clearly and explicitly includes the identifier of the data it describes
“Correlative results include data from immunohistochemistry (IHC) of both tumor and immune microenvironment, DNA sequencing, RNA expression data, and molecular pathway analysis.”
The dataset content is described in running prose without an itemised inventory like a section or table. [majority verdict 'partial' (4/5 passes agreed)]
RDA-F2-01M — 'Rich metadata is provided to allow discovery' (priority Essential) · FsF-F2-01M — F-UJI: 'Metadata includes descriptive core elements to support data findability' · FsF-R1-01MD — F-UJI: 'Metadata specifies the content of the data'
“Data are available, via controlled access, from the NCBI dbGaP archive (database accession number phs003785.v1).”
The access route carries a stated precondition ('controlled access'), which is a followable process but not unconditional.
RDA-A1.1-01D — 'Data is accessible through a free access protocol' · FsF-A1-01M — F-UJI: 'Metadata contains access level and access conditions of the data' · NSTC Desirable Characteristics of Data Repositories (2022) — 'Free and Easy Access'
Advisory · not in the published score
“Data are available, via controlled access, from the NCBI dbGaP archive (database accession number phs003785.v1).”
The text explicitly labels the access level as 'controlled access'.
FsF-A1-01M — F-UJI: 'Metadata contains access level and access conditions of the data' · RDA-A1-01M — metadata contains information to enable the user to get access to the data · COAR Controlled Vocabularies — Access Rights v1.0 (open / embargoed / restricted / metadata-onl
“Data are available, via controlled access, from the NCBI dbGaP archive (database accession number phs003785.v1).”
The named gatekeeper is the NCBI dbGaP archive, an institutional controlled-access repository.
NIH Genomic Data Sharing Policy (NOT-OD-14-124) — controlled-access via a Data Access Committee · RDA-A1.2-01D — 'Data is accessible through an access protocol that supports authentication and · NIH DMS Policy Element 5 (NOT-OD-21-014) — Access, Distribution, or Reuse Considerations (conse
No sentence in the text states when the data become available or how long they persist. [majority verdict 'no' (4/5 passes agreed)]
NIH DMS Plan Element 4 (NOT-OD-21-014) — Data Preservation, Access, and Associated Timelines · NSTC Desirable Characteristics (2022), Organizational Infrastructure: 'Retention Policy' · RDA-A2-01M — 'Metadata is guaranteed to remain available after data is no longer available'
No file format is named for the released data; only sequencing methods are described. [majority verdict 'no' (2/5 passes agreed)]
FsF-R1.3-02D — F-UJI: 'Data is available in a file format recommended by the target research co · RDA-R1.3-02D — data is expressed in a machine-understandable community standard · RDA-I1-01D — data uses a knowledge representation expressed in a standardised format
Advisory · not in the published score
No data or metadata community standard (e.g., MIAME, Dublin Core, an OBO ontology) is named for the data. [majority verdict 'no' (4/5 passes agreed)]
RDA-R1.3-01M — 'Metadata complies with a community standard' (priority Essential) · RDA-R1.3-01D — 'Data complies with a community standard' · RDA-I2-01M — '(Meta)data use vocabularies that follow FAIR principles'
No identifier for an external resource (e.g., source dataset, reference database, code) is provided in the text. [majority verdict 'no' (3/5 passes agreed)]
RDA-I3-01M — '(meta)data include references to other (meta)data' · RDA-I3-03M — 'metadata includes qualified references to other metadata' · FsF-I3-01M — F-UJI: 'Metadata includes links between the data and its related entities'
No license or terms-of-use is named for the data; the CC BY-NC license applies only to the article.
RDA-R1.1-01M — 'Metadata includes information about the licence under which the data can be reu · RDA-R1.1-02M — 'Metadata refers to a standard reuse licence' · RDA-R1.1-03M — 'Metadata refers to a machine-understandable reuse licence'
“Data are available, via controlled access, from the NCBI dbGaP archive (database accession number phs003785.v1).”
The accession includes a version token: '.v1'.
DataCite Metadata Schema 4.6 — the 'Version' property · RDA-R1.2-01M — provenance information (which version was used is provenance) · NSTC Desirable Characteristics of Data Repositories (2022) — 'Provenance', 'Retention Policy'
No code locator is given for the study's own code; only third-party tools are mentioned.
NIH DMS Policy Element 2 (NOT-OD-21-014) — 'Related Tools, Software and/or Code' · FAIR4RS Principles v1.0 (Chue Hong et al., 2022; RDA/FORCE11/ReSA) — FAIR Principles for Resear · FORCE11 Software Citation Principles (Smith, Katz & Niemeyer, 2016, PeerJ CS 2:e86)
“supported by the National Cancer Institute of the National Institutes of Health (U10CA180821, U10CA180882, U24CA196171 (to the Alliance for Clinical Trials in Oncology), UG1CA233180, UG1CA233290, UG1CA233331, UG1CA233339, and P30CA08748 (to Memorial Sloan Kettering Cancer Center))”
Award/grant numbers are provided for the funder.
DataCite Metadata Schema 4.6 — 'FundingReference' property (funderName, funderIdentifier, award · Crossref Funder Registry — canonical funder identifiers for funding metadata · RDA-F2-01M — rich metadata provided to allow discovery (funding is part of the descriptive reco
Advisory · not in the published score
“sequencing using Illumina Hiseq”
The text names specific instruments and software (e.g., Illumina Hiseq, STAR V.2.7.0, Burroughs-Wheeler Aligner-MEM). [majority verdict 'yes' (4/5 passes agreed)]
RDA-R1.2-01M — 'Metadata includes provenance information according to community- specific standa · FsF-R1.2-01M — F-UJI: 'Metadata includes provenance information about data creation or generati · W3C PROV-O (W3C Recommendation, 2013) — the entity/activity/agent model of provenance
No documentation object (README, data dictionary, codebook) is named as accompanying the data, and no variable-definition table exists inside the article.
RDA-R1-01M — '(Meta)data are richly described with a plurality of accurate and relevant attribu · FsF-R1-01MD — F-UJI: 'Metadata specifies the content of the data' · NIH DMS Policy Element 3 (NOT-OD-21-014) — Standards (documentation and metadata to accompany t
Calibrated FAIR score — a parallel quality metric, independent of the DataRank citation score. See the full evaluation →
Base Score Contribution
0.425
From this paper's citation signal
Citation Network Contribution
0.193
From 7 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 14 citers.
Cycle for Survival
Grant: n/a
National Cancer Institute of the National Institutes of Health
Grant: P30CA08748
National Cancer Institute of the National Institutes of Health
Grant: U10CA180821
National Cancer Institute of the National Institutes of Health
Grant: U10CA180882
National Cancer Institute of the National Institutes of Health
Grant: U24CA196171
National Cancer Institute of the National Institutes of Health
Grant: UG1CA233180
National Cancer Institute of the National Institutes of Health
Grant: UG1CA233290
National Cancer Institute of the National Institutes of Health
Grant: UG1CA233331
National Cancer Institute of the National Institutes of Health
Grant: UG1CA233339
NCI NIH HHS
Grant: P30 CA086862
NCI NIH HHS
Grant: P30 CA008748
National Institutes of Health
Grant: 3U10CA180821-02S2
Alliance for Clinical Trials in Oncology Operations Center
National Institutes of Health
Grant: 5UG1CA233180-02
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
National Institutes of Health
Grant: 5UG1CA233331-03
OSU as a Network Lead Academic Participating Site for the NCI NCTN
National Institutes of Health
Grant: 3UG1CA233339-06S1
Washington University/Siteman Cancer Center Lead Academic Site
National Institutes of Health
Grant: 3U24CA196171-04S1
THE ALLIANCE NCTN BIOREPOSITORY AND BIOSPECIMEN RESOURCE
National Institutes of Health
Grant: 3UG1CA233290-06S1
Lead Academic Participating Site: Memorial Sloan Kettering Cancer Center
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 5U10CA180882-02
Statistics and Data Center for the Alliance for Clinical Trials in Oncology
Fields of Study
MeSH Terms
Keywords